Opus Small Cap Value Plus ETF (BATS:OSCV – Get Free Report) was the target of a significant drop in short interest in October. As of October 15th, there was short interest totaling 1,579 shares, a drop of 82.2% from the September 30th total of 8,894 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 91,982 shares, the days-to-cover ratio is currently 0.0 days.
Institutional Trading of Opus Small Cap Value Plus ETF
An institutional investor recently raised its position in Opus Small Cap Value Plus ETF stock. Princeton Global Asset Management LLC lifted its stake in shares of Opus Small Cap Value Plus ETF (BATS:OSCV – Free Report) by 61.6% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,539 shares of the company’s stock after purchasing an additional 1,349 shares during the period. Princeton Global Asset Management LLC’s holdings in Opus Small Cap Value Plus ETF were worth $140,000 at the end of the most recent quarter.
Opus Small Cap Value Plus ETF Stock Performance
Shares of Opus Small Cap Value Plus ETF stock opened at $40.68 on Tuesday. The firm has a market cap of $659.02 million, a PE ratio of 18.31 and a beta of 0.92. The business’s 50 day simple moving average is $40.80 and its 200 day simple moving average is $40.73. Opus Small Cap Value Plus ETF has a 52-week low of $35.93 and a 52-week high of $43.29.
Opus Small Cap Value Plus ETF Company Profile
The Opus Small Cap Value Plus ETF (OSCV) is an exchange-traded fund that mostly invests in small-cap stocks. The fund is an actively managed fund that selects US small-cap companies and REITs based on valuation plus quality and growth metrics. The fund seeks capital appreciation. OSCV was launched on Jul 18, 2018 and is managed by Opus Capital Management.
Recommended Stories
- Five stocks we like better than Opus Small Cap Value Plus ETF
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Opus Small Cap Value Plus ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opus Small Cap Value Plus ETF and related companies with MarketBeat.com's FREE daily email newsletter.
